Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUSE follow-up study of atorvastatin muscle side effects in coronary patients
2019-003959-11Phase 4Completed
- Sponsor
- Vestre Viken Hospital Trust
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of atorvastatin in coronary arteriosclerosis (2 arms), sponsored by Vestre Viken Hospital Trust. Started Mar 2020; status: completed.
02
Drugs
atorvastatin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2019-003959-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003959-11.